← All Yijia Group CORP filings

Yijia Group CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

YJGJ
Yijia Group CORP
10-K: VitaNova Life Sciences Reports FY26 Results, Revenue Up 14%
VitaNova Life Sciences Corporation's annual report for fiscal year 2026 shows a 14% increase in revenue to $3.03 million, driven by its new healthy food products line, though net income turned to a loss of $37,304.
YJGJ
Yijia Group CORP
10-K: Yijia Group Reports Soaring Revenue and Profit Driven by Healthcare Segment Growth Amidst Internal Control Concerns
Yijia Group Corp. announced significantly increased revenues and net income for fiscal year 2025, primarily fueled by the rapid expansion of its healthcare products segment, despite ongoing internal control deficiencies.
YJGJ
Yijia Group CORP
10-K: Yijia Group Corp. Reports Significant Revenue Growth in Fiscal Year 2024 Driven by Healthcare Segment
Yijia Group Corp. experienced a substantial increase in revenue during fiscal year 2024, primarily due to the expansion of its healthcare product sales.